Related Research Articles
Falkenstein Castle (Oberfalkenstein) is a ruined medieval castle near Obervellach in Carinthia, Austria. It was built in the 12th century as part of a larger fortification complex comprising the preserved advanced work of Niederfalkenstein below.
Burgruine Flaschberg is a castle in Carinthia, Austria.
Burgruine Greifenfels is a castle in Carinthia, Austria.
Burgruine Hartneidstein is a castle in Carinthia, Austria.
Burgruine Leobenegg is a castle in Carinthia, Austria.
Burgruine Lichtengraben/Painburg is a castle in Carinthia, Austria.
Burgruine Liemberg is a ruined castle in Carinthia, Austria, west of the town of the same name in the municipality of Liebenfels on the steep slope of the Göseberg.
Burg Mannsberg is a castle in Carinthia, Austria.
Burgruine Moosburg/Arnulfsfeste is a castle in Carinthia, Austria.
Schloss Rosegg is a castle in Rosegg, Carinthia, Austria. Schloss Rosegg is 478 metres (1,568 ft) above sea level.
Burgruine Sternberg is a castle in Carinthia, Austria.
Burgruine Waisenberg is a castle in Carinthia, Austria.
Burgruine Weidenburg is a large castle in Carinthia, Austria.
Ruine Klöch is a castle in Styria, Austria.
Ruine Ligist is a castle in Styria, Austria. Ruine Ligist is situated at an elevation of 386 m.
Burgruine Wildon is a castle in Styria, Austria.
Burg Bruck is a medieval castle in Lienz in Tyrol, Austria. Burg Bruck is 711 metres (2,333 ft) above sea level.
Burg Heinfels is a castle in Heinfels, Tyrol, Austria.
Opprebais Castle is a 13th-century fortified farmhouse (château-ferme) in Opprebais, Wallonia, in the municipality of Incourt, Walloon Brabant, Belgium.
A-796,260 is a drug developed by Abbott Laboratories that acts as a potent and selective cannabinoid CB2 receptor agonist. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in most indole derived cannabinoids with the 3-tetramethylcyclopropylmethanone group, imparts significant selectivity for CB2, and A-796,260 was found to be a highly selective CB2 agonist with little affinity for CB1, having a CB2Ki of 4.6 nM vs 945 nM at CB1. It has potent analgesic and anti-inflammatory actions in animal models, being especially effective in models of neuropathic pain, but without producing cannabis-like behavioral effects.
References
 | This Carinthia location article is a stub. You can help Wikipedia by expanding it. |
  | This article about a castle in Austria is a stub. You can help Wikipedia by expanding it. |